| Literature DB >> 30128146 |
Rodolfo G Gatto1, Manish Y Amin2, Daniel Deyoung2, Matthew Hey3, Thomas H Mareci4, Richard L Magin5.
Abstract
BACKGROUND: Amyotrophic lateral sclerosis (ALS) is a disease characterized by a progressive degeneration of motor neurons leading to paralysis. Our previous MRI diffusion tensor imaging studies detected early white matter changes in the spinal cords of mice carrying the G93A-SOD1 mutation. Here, we extend those studies using ultra-high field MRI (17.6 T) and fluorescent microscopy to investigate the appearance of early structural and connectivity changes in the spinal cords of ALS mice.Entities:
Keywords: Amyotrophic Lateral Sclerosis; Axonal Degeneration; Connectomics; Diffusion Tensor Imaging; G93A-SOD1 mice; Spinal Cord; Tractography; Ultra-high Field MRI; Yellow Fluorescent Protein
Year: 2018 PMID: 30128146 PMCID: PMC6097419 DOI: 10.1186/s40035-018-0122-z
Source DB: PubMed Journal: Transl Neurodegener ISSN: 2047-9158 Impact factor: 8.014
Fig. 1Ex vivo analysis of presymptomatic spinal cord of ALS mice by Ultra-High Field MRI diffusion. a Scheme representing MRI cross- sections from different spinal cord segments (cervical, thoracic, and lumbar) used for analysis. b T2w representative MR images from individual spinal cords scans showing the white matter (WM) ROIs in the WM anterolateral funiculus (white dotted line) from each spinal cord segment (YFP vs. G93A-SOD1 mice) Scale bar = 1 mm. Abbreviations: WM: white matter. YFP: yellow fluorescent protein
Fig. 2Early axonal structural changes can be observed in spinal cord of ALS mice. a Spinal cord lumbar sections from an YFP, G93A-SOD1 mouse. Regions of Interest (ROI) were obtained from the anterior portion of the spinal cord (SC) white matter (WM) (white square area). Detailed changes in axonal diameter can be seen in the YFP, G93A-SOD1 mice. Note that each WM area in the histology pictures has an approximate voxel size (100 × 100 μm2). Scale bar =1 mm. b Measurements from WM ROIs showed a significant (**p < 0.01) reduction in in axonal areas and an increase in the number of YFP-positive axons (axonal density contained within 100 μm2) in the presymptomatic (P80) YFP, G93A-SOD1 mice. (* = p < 0.05); (** = p < 0.01) (n = 4/5 per group). Nuclear counterstaining with DAPI (blue). Scale bar =10 μm. Abbreviations: WM, white matter; GM, grey matter; YFP, yellow fluorescent protein
Fig. 4Presymptomatic white matter fiber from the YFP, G93A-SOD1 mice are associated to quantitative changes in axonal connectivity. a Quantitative analysis of Fractional Anisotropy (FA), Axial Diffusion (AD) and Radial Diffusion (RD) from spinal cord (SC) white matter (WM) showing a significant decrease in FA and AD and an increase in RD in the YFP, G93A-SOD1 (ALS) mice compared with controls (*p < 0.05) (**p < 0.01), (***p < 0.001) (n = 4/5). b Statistical analysis of Edge Weight analysis from ROIs showing statistical differences in presymptomatic (P80) WM connectivity in the YFP, G93A-SOD1 mice compared with controls. (* = p < 0.05), (** = p < 0.01). Abbreviations: YFP, yellow fluorescent protein; P80, postnatal day 80 (presymptomatic)
Fig. 3Fiber organization tractography anomalies and ultrastructural histological changes in axons from ALS mice. a Representative WM tractography fiber reconstructions from lumbar spinal cord sections showing early changes in microstructural organization. Scale bar =1 mm. b Three-dimensional confocal z-stack reconstructions from spinal cord WM (white square) showing early axonal structural anomalies in the YFP, G93A-SOD1 (ALS) mice. Scale bar =10 μm. Abbreviations: WM, white matter; YFP, yellow fluorescent protein
Fig. 5Changes MRI diffusion are coupled with aquaporin expression anomalies in ALS white matter. a Quantitative measurements from apparent diffusion coefficient (ADC) spinal cord maps showing an increase in lower SC segments (dorsal and lumbar levels) in the ALS mice. b Progressive changes in aquaporin 4 (AQP4) expression can be seen in the presymptomatic and symptomatic YFP, G93A-SOD1 mice. Scale bar = 1 mm. c Further analysis of SC white matter (WM) shows a significant increase in AQP4 expression in the presymptomatic ALS mice compared to control, mostly located in the extra- axonal compartment. (*** = p < 0.001). Nuclear counterstaining with DAPI (blue). Scale bar = 10 μm. Abbreviations: YFP, yellow fluorescent protein; P80, postnatal day 80 (Presymptomatic); P120, postnatal day 120 (Symptomatic)
Previous Spinal Cord Studies in ALS Using Diffusion Tensor Imaging (DTI)
| Research group | Experimental Setup | Diffusion Coefficients | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Author | Year | Animal Models & Subjects | Cohort | MRI instrument | ROI | SC Level | FA | AD | RD | MD |
| Gatto et al. [ | 2018 | B6JL G93A-SOD1 | G93A-SOD1 (n = 5) | 9.4 T Bruker Agilent | WM(ALF) | C,D,L | Decrease(WM) | Decrease(WM) | Increase(WM) | Increased(WM) |
| Fukuri et al. [ | 2017 | Clinical | ALS patients (n = 38) | 3 T Siemens | WM | C5 | Decrease | Not Evaluated | Not Evaluated | Unchanged |
| Mancuzzo et al. [ | 2017 | B6JL G93A-SOD1 | G93A-SOD1 (n = 7) | 7 T Bruker BioSpec | D,DR,DL,V,VR,VL | L | Decrease | Unchanged (PS) Decrease (S) | Unchanged | Decrease |
| Rasoanandrianina et al. [ | 2017 | Clinical | ALS patients (n = 10), | 3 T Siemens | WM (CST, PST) | C2-C5 | Decrease WM | Decrease(WM) | Increase(WM) | Not Evaluated |
| Budrewicz et al. [ | 2016 | Clinical | ALS patients (n = 15), | 1.5 T GE Medical systems | ACST,PCST, LCST, GM | C1-C5 | Decrease | Not Evaluated | Not Evaluated | Not Evaluated |
| Figini et al. [ | 2016 | B6JL - G93A-SOD1 | G93A-SOD1 (n = 7) vs | 7 T Bruker BioSpec | VMT, dT, VLT, DLT, GM | L | Decrease | Unchanged (PS) Decrease (S) | Increase | Increase |
| Caron et al. [ | 2015 | 129Sv G93A-SOD1 | C57 G93A-SOD1 (n = 6) | 7 T Bruker BioSpec | VMT,VLT,DLT, dT | L | Decrease | Unchanged (PS) Decrease (S) | Increase | Not Evaluated |
| Iglesias et al. [ | 2015 | Clinical | ALS patients (n = 20) | 3 T Siemens | PMT, CST | C5- D1 | Decrease | Unchanged | Increase | Increase |
| Wang et al. [ | 2014 | Clinical | ALS patients (n = 24), | 1.5 T GE healthcare | ST, LCST | C1-C2 | Decrease | Not Evaluated | Not Evaluated | Not Evaluated |
| Romano et al. [ | 2014 | Clinical | ALS patients (n = 14) | 1.5 T Siemens | CST | C,D,L | Decrease | Unchanged | Increase | Increase |
| El MendilI et al. [ | 2014 | Clinical | ALS patients (n = 14) | 3 T Siemens Trio | CST | C2 to T6 | Decrease | Unchanged | Increase | Increase |
| Cohen- Adad et al. [ | 2013 | Clinical | ALS patients (n = 29) | 3 T Siemens Trio | PSCT, LSCT | C2 to T2 | Decrease | Decrease/Unchanged | Increase | Not Evaluated |
| Kim et al. [ | 2011 | B6JL G93A-SOD1 | G93A-SOD1 (n = 5) | 4.7 T Oxford Instruments | VLT, dT | C & L | Decrease | Decrease | Increase | Not Evaluated |
| Underwood et al. [ | 2011 | C57 G93A-SOD1 | G93A-SOD1 (n = 6) | 16.4 T Bruker | DF,VF,VLF,DLF | D12-L1 | Decrease | Decrease | Increase | Not Evaluated |
| Nair et al. [ | 2010 | Clinical | ALS patients (n = 14) | 3 T Siemens Trio | CST | C1-C6 | Decrease | Unchanged | Increase | Increase |
| Agosta et al. [ | 2009 | Clinical | ALS patients (n = 17) | 1.5 T Siemens Avanto | CST | C2-C3 | Decrease | Not Evaluated | Not Evaluated | Increase |
| Valsalina et al. [ | 2007 | Clinical | ALS patients (n = 28) | 1.5 T Siemens Avanto | CST | C2-C3 | Decrease | Not Evaluated | Not Evaluated | Decrease |
| Rossi et al. [ | 2007 | Clinical | ALS patients (n = 1) | 1.5 T and 3 T Scanner | CST | C | Decrease | Not Evaluated | Not Evaluated | Decrease |
Summary of previous studies using DTI to investigate microstructural changes in ALS spinal cord
Abbreviations: FA Fractional Anisotropy SC Spinal Cord, C Cervical segment, D Dorsal segment, L Lumbar segment, RD Radial Diffusion, AD Axial Diffusion, MD Mean Diffusion, ROI Region of interest, CST Corticospinal Tracts, LCST Lateral Corticospinal Tracts, PCST Posterior Corticospinal Tract, ACST Anterior Corticospinal Tract, CMG Central Grey matter, ST Spinothalamic Tract, PMT Posterior Medial Tract, CMG Central Grey Matter, ST Spinothalamic Tracts, PMT Posterior Medial Tract, VMT Ventromedial Tract, PS Presymptomatic, S Symptomatic, dT Dorsal Tract, VLT Ventrolateral Tract, DLT Dorsolateral Tract, DF Dorsal Funiculi, VF Ventral Funiculi, VLF Ventrolateral Funiculi, DLF Dorsolateral Funiculi.[Source: PubMed. Key words: ALS / DTI /Spinal Cord /Diffusion Tensor imaging]
Fig. 6Diagram representing axonal structural changes detected by UHF-MRI and histology in ALS mice. a High magnification of axial section from spinal cord white matter (WM) in YFP control and YFP, G93A-SOD1 mice. b Diagram showing a reduction in axonal area and increased axonal density in the ALS mice. c - Graph displaying the relative changes in the membrane content (decrease in MBP described in Gatto et al. 2018 [31]), and relative decrease in axonal compartment and increase in the extra-axonal compartment. Note that concurrent changes in axonal compartment and membranes occurs without changes in G-ratios. Scale bar = 10 μm. Abbreviations: YFP, yellow fluorescent Protein; WM, white matter; GM: grey matter, MBP: myelin basic protein. AD: axial diffusion, RD: radial diffusion. G-ratio: ratio of the inner axonal diameter to the total outer diameter
Presymptomatic UHF-MRI Diffusion Bioimaging Markers at 17.6T and Histological Findings in ALS Mice Spinal Cord
| MRI markers | White Matter Microstructure | Histology/Molecular Markers |
|---|---|---|
| FA ↓ | Axonal Organization | YFP labeled axons |
| RD ↑ | Myelin Content | MBP |
| AD ↓ | Axonal Degeneration | YFP labeled axons |
| EW ↓ | Axonal Connectivity | YFP labeled axons |
| ADC ↑ | Transmembrane Water Diffusion | AQP4 |
Presymptomatic white matter changes in UHF-MRI diffusion can be associated to biological and molecular markers of axonal ultrastructure & connectivity and other cellular compartments
Abbreviations: ALS Amyotrophic lateral Sclerosis, WM White matter, ADC Apparent diffusion coefficient, RD Radial Diffusivity, AD Axial diffusivity, FA Fractional Anisotropy, EW Edge Weight, AQP4 Aquaporin 4, MBP Myelin Basic Protein, YFP Yellow fluorescent Protein. (* Presymptomatic changes in MBP seen in Gatto et al. 2018 [28])